Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 04 - 13 tags : Disease save search
Outlook on the End Stage Renal Disease Global Market to 2025 - Competitive Analysis and Impact of COVID-19
Published: 2021-04-13 (Crawled : 22:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.17%
H: 0.5%
C: 0.34%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.02%
H: 1.02%
C: 0.24%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.67%
H: 0.11%
C: -0.41%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.27%
H: 0.33%
C: 0.09%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.56%
H: 0.18%
C: -0.4%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.01%
H: 0.61%
C: -0.14%
covid disease renal
Longeveron Announces Positive Results of Phase I Clinical Study of Lomecel-B Cell Therapy for Alzheimer’s Disease
Published: 2021-04-13 (Crawled : 15:00) - biospace.com/
LGVN 1 d | $1.93 -3.98% -4.15% 460K
|
|
| O: 32.23%
H: 2.4%
C: -20.0%
disease alzheimer positive results positive therapy results lomecel-b alzheimer’s alzheimer's disease t-cell alzheimer's
Quidel Corporation Partners With the Bay Area Lyme Foundation to Heighten Public Awareness of Lyme Disease
Published: 2021-04-13 (Crawled : 13:00) - biospace.com/
QDEL | News M | $39.09 2.17% 2.12% 1.1M
|
Health Technology
|
| O: 0.75%
H: 3.12%
C: 1.04%
disease
Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction
Published: 2021-04-13 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: 0.03%
H: 0.17%
C: -0.5%
dry eye disease eye eye disease results topline phase 3 trial
Akouos Receives Orphan Drug and Rare Pediatric Disease Designations for AK-OTOF for the Treatment of Otoferlin Gene-Mediated Hearing Loss
Published: 2021-04-13 (Crawled : 13:00) - globenewswire.com
AKUS | $13.29 1.07% 3.46%
|
Health Technology
|
| O: -1.1%
H: 8.22%
C: -1.18%
disease media treatment drug hearing loss designation rare
BridgeBio Pharma and Brown University Announce Partnership to Drive the Advancement of Academic Innovations in Genetically Driven Diseases into Potential Therapeutics for Patients
Published: 2021-04-13 (Crawled : 13:00) - biospace.com/
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
disease partnership genetic potential
BridgeBio Pharma, Inc. and GlycoNet Initiate Collaboration to Discover Potential Treatments for Genetic Diseases through Glycomics Research
Published: 2021-04-13 (Crawled : 12:00) - globenewswire.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
disease treatment genetic potential collaboration research
BridgeBio Pharma, Inc. and Oregon Health & Science University Establish Collaboration to Translate Pioneering Research into Therapies for Genetically Driven Diseases
Published: 2021-04-13 (Crawled : 12:00) - globenewswire.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
disease genetic collaboration research therapy
BridgeBio Pharma, Inc. and UC Davis Establish Collaboration to Transform Research into Potential Therapies for Genetically Driven Diseases
Published: 2021-04-13 (Crawled : 12:00) - biospace.com/
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 0.43%
H: 2.42%
C: 0.76%
disease genetic potential collaboration research therapy
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.